RE:RE:Do I have this straight ?Fair enough comment. I simply think, as someone else mentioned, if extra cash is needed to kickstart the other trials such as NSCLC and get those expedited then it's no skin off Roger's back to float the money when he knows it's coming right back to him exponentially. Imagine the fomo component which would kick in if the December CR numbers improve significantly with our bladder trial with new studies funded and underway on top of everything else. Would this not add huge value to the company, JV opportunities, or perhaps Li Ka Shing wanting a piece of the action? After all even billionaires are scared of missing out on their next billion.